Article
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.
Gynecologic oncology - 1 Jan 2020
Stasenko Marina, Tunnage Irina, Ashley Charles W, Rubinstein Maria M, Latham Alicia J, Da Cruz Paula Arnaud, Mueller Jennifer J, Leitao Mario M, Friedman Claire F, Makker Vicky, Soslow Robert A, DeLair Deborah F, Hyman David M, Zamarin Dimitriy, Alektiar Kaled M, Aghajanian Carol A, Abu-Rustum Nadeem R, Weigelt Britta, Cadoo Karen A
Abstract excerpt
OBJECTIVES: Assess outcomes of a clinical cohort of patients with endometrioid endometrial cancer (EEC) harboring somatic POLE exonuclease domain mutations (EDMs). METHODS: Patients were consented to a protocol of tumor-normal massively parallel sequencing of 410-468 cancer related genes. EECs subjected to sequencing from 2014 to 2018 were reviewed. Tumors with somatic POLE EDMs were identified. EECs were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
